CN101104031B - Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer - Google Patents

Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer Download PDF

Info

Publication number
CN101104031B
CN101104031B CN2007100161179A CN200710016117A CN101104031B CN 101104031 B CN101104031 B CN 101104031B CN 2007100161179 A CN2007100161179 A CN 2007100161179A CN 200710016117 A CN200710016117 A CN 200710016117A CN 101104031 B CN101104031 B CN 101104031B
Authority
CN
China
Prior art keywords
grams
radix
chinese medicine
medicine composition
treating nasopharyngeal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100161179A
Other languages
Chinese (zh)
Other versions
CN101104031A (en
Inventor
冯桂青
刘莹
张伟红
李文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Feng Guiqing
Liu Ying
Zhang Weihong
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007100161179A priority Critical patent/CN101104031B/en
Publication of CN101104031A publication Critical patent/CN101104031A/en
Application granted granted Critical
Publication of CN101104031B publication Critical patent/CN101104031B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an oral Chinese herbal compound for treating nasopharyngeal darcinoma, belonging to the Chinese traditional medicine. The oral Chinese herbal compound for treating nasopharyngeal darcinoma is prepared with the following weights of raw materials: 40g of gypsum, 6g of processed rhubarb, 5g of szechwan lovage rhizome, 4g of cicada slough, 30g of radix rehmanniae, 30g of figwort, 10g of cortex moutan, 10g of licorice products, 10g of honeysuckle, 20g of prunella vulgaris and 6g of liquorice. The herbs are decocted in water for oral taking; one dose of the decoction is taken in one day; each dose is decocted for two times and separated for taking in the morning and in the evening. The oral Chinese herbal compound for treating nasopharyngeal is reasonable in prescription, convenient in preparation, used for remedying incomplete treatment to the nasopharyngeal and various side effects by radiochemotheraphy, and evident for the treatment effect.

Description

A kind of Chinese medicine composition of orally taken for curing nasopharyngeal carcinoma
Technical field
The present invention relates to a kind of Chinese medicine composition of orally taken for curing nasopharyngeal carcinoma, belong to the field of Chinese medicines.
Background technology
Nasopharyngeal carcinoma is common malignant tumor, is more common in southern all provinces such as Guangdong, Guangxi.Have certain region and ethnic identity, family's tendentiousness is arranged, 30-50 year is high age of onset, and the male sees than the women more.Main clinical manifestation is the symptom (neuralgia, headache, eyeball paralysis, Hiccough and deaf etc.) after blood tears, cervical lymph node enlargement and cancer are invaded cranial nerve, nasopharyngeal endoscope can be looked into and see that cavum nasopharyngeum has the cauliflower-like thing that swells, color is greyish white, rough surface or have ulcer, touch easily hemorrhage.Symptom: hidden in the nasopharynx position, check to be difficult for that the early symptom more complicated of nasopharyngeal carcinoma lacks feature simultaneously, so ignored by the people easily, so delay diagnosis and treatment are must enhancing your vigilance property.Common sympton has: 1. hemorrhage: mainly be tough middle band blood behind the suction nose, or nose goes out to be with the blood nasal mucus.Beginning be a small amount of blood streak often, and is out in the cold easily, reach to amount of bleeding more for a long time, during often pathological changes has been gone into, late period.2. headache: just headache can be arranged in early days, and how amesiality, be intermittent; Late period then occurs the persistence severe headache, think nervous migraine easily by mistake.3. cervical lymph node enlargement: lump appears in a side or bilateral neck, incapability, and matter is harder, and mobility is poor, and Chang Yi thinks lymphoid tuberculosis or lymphadenitis by mistake.4. other symptoms: except that above-mentioned some or all symptoms of performance, nasal obstruction, deafness, tinnitus also can occur and portion's numbness, diplopia, go up symptoms such as the danger is sagging.Late period, cancerous protuberance was easily to metastasis such as intracranial infringement and bone, liver, lungs.Diagnosis: pharyngorhinoscopy is to find swollen the most effective, the reliable method of pain, makes a definite diagnosis at last and will lean on biopsy slice.The Epstein-Barr virus Serological testing helps early discovery.Liver spleen B ultrasonic, chest, basis cranii photo or CT are swept inspection such as cat and are invaded scope and have or not metastasis meaningful understanding pathological changes.
Nasopharynx part adopted put, chemotherapy can improve radiotherapeutic effect.Operation clinically, radiotherapy, chemotherapy all have certain curative effect, but relapse and metastasis still unavoidably takes place, the state of an illness repeatedly, the course of disease is touching.The nasopharyngeal carcinoma great majority have been middle and advanced stage once finding, have lost the radical cure chance, also can't carry out chemotherapy and radiotherapy.
Summary of the invention
The objective of the invention is to overcome the deficiency of existing treatment, and a kind of Chinese medicine composition of orally taken for curing nasopharyngeal carcinoma is provided, all select natural Chinese medicinal herb for use, can effectively treat behind the nasopharyngeal carcinoma chemicotherapy nose massive hemorrhage and the state of an illness repeatedly.
Technical scheme of the present invention is: the Chinese medicine composition of this kind orally taken for curing nasopharyngeal carcinoma, it is characterized in that, making the raw materials of effective components medicine by following weight is: Gypsum Fibrosum 40 grams, Radix et Rhizoma Rhei (processed) 6 grams, Rhizoma Chuanxiong 5 grams, the Radix Angelicae Dahuricae 5 grams, Periostracum Cicadae 4 grams, the Radix Rehmanniae 30 grams, Radix Scrophulariae 30 grams, Cortex Moutan 10 grams, Preparatum Glycyrrhizae's 10 grams, Flos Lonicerae 10 grams, Spica Prunellae 20 grams and Radix Glycyrrhizae 6 grams.
Be decocted in water for oral dose.1 dose of every day, fry in shallow oil 2 times sub-service sooner or later for every dose.
Pharmacological action:
Gypsum Fibrosum: control the calentura high fever and do not move back, vexed coma, delirium is gone mad, thirsty and dry pharynx, the lung-heat dyspnea with rapid respiration, the heatstroke spontaneous perspiration, stomach-fire headache, toothache, hyperactivity of toxic heat is sent out the speckle dermexanthesis, aphtha of the mouth and tongue.
Radix et Rhizoma Rhei (processed): hardship, cold.Return spleen, stomach, large intestine, liver, pericardium channel.Purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.
Rhizoma Chuanxiong: air to open is strongly fragrant, dispeiling pathogenic wind and removing dampness, promoting blood circulation and stopping pain.Control air-cooled headache, revolve dizzyly, the hypochondriac pain abdomen is painful, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation piece pain, ulcer sores.
The Radix Angelicae Dahuricae: dispel the wind dampness, detumescence, pain relieving.Control headache, supraorbital bone pain, toothache, nasal sinusitis, cold-damp stomachache, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, ulcer sores, skin pruritus due to dryness, scabies.
Periostracum Cicadae: the wind heat of loosing, lung qi dispersing is decided convulsion.Control affection due to external wind and heat, the cough hoarseness, measles is sent out not smooth thoroughly, rubella pruritus, pediatric epilepsy scared, conjunctival congestion, cataracta, furuncle swelling toxin, tetanus.
The Radix Rehmanniae: clearing away heat and cooling blood, be used for the heat in blood poison and contain, hematemesis and epistaxis, macule is purple black, YIN nourishing and the production of body fluid promoting, interior-heat is quenched one's thirst.
Radix Scrophulariae: bitter, sweet, salty, cold.Return lung, stomach, kidney channel.The function YIN nourishing, pathogenic fire reducing, relieving restlessness, detoxifcation.Curing mainly swollen joint, enclosed mass due to hard masses softening and resolving, the treatment phlegm-fire accumulation of heat, is product on the treatment goiter.
Cortex Moutan: cold in nature, bitter in the mouth, suffering.Clearing away heat and cooling blood, blood circulation promoting competent silt.Be used for maculae caused by violent heat pathogen, tell, be defeated in battle, have blood in stool, the hectic fever due to YIN-deficiency consumptive fever, the amenorrhea dysmenorrhea, carbuncle sore tumefacting virus falls and pounces on the pain of injury.
Preparatum Glycyrrhizae: heat clearing away, removing heat from blood, detoxifcation.Cold and heat disease, big hot excessive thirst, maculopapulae due to toxic heat, erysipelas, skin infection cure the wound.
Flos Lonicerae: heat clearing away, detoxifcation.Control the epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle and ulcer.Toxic swelling, scrofula, anal fistula.
Spica Prunellae: relieve inflammation or internal heat, make eye bright, eliminating stagnation, detumescence.Be used for conjunctival congestion and swelling pain, order pearl nyctalgia, it is dizzy to have a headache, scrofula, goiter, acute mastitis swells and ache; Thyromegaly, tuberculous lymphadenitis, cyclomastopathy, hypertension.
Radix Glycyrrhizae: and middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.Control weakness of the spleen and stomach, lack of appetite, the stomachache loose stool, the overstrain heating, the consumptive lung disease cough, cardiopalmus is fainted from fear.
The present invention with above drug regimen after, drug effect has synergism.The Chinese medicine composition composition formula of this kind orally taken for curing nasopharyngeal carcinoma is reasonable, easy to prepare, is used for many side effect that the treatment of nasopharyngeal carcinoma chemicotherapy is thorough inadequately and cause, effect is remarkable.
Model case:
Example one: high certain, the man, 65 years old, the patient was diagnosed as advanced NPC last year, through the chemotherapy course of treatment (twice), back 40 radiotherapies take a turn for the better in March, 2007 and to leave hospital, and have only little one or two lump to dissipate fully.Now have sore throat (may be that radiotherapy causes); Sound is still hoarse; Cough slightly, abundant expectoration is white; Sense of obstruction (there is foreign body sensation at the neck middle part) is arranged, inappetence when swallowing food.CT result shows by the end of March, and lump does not disappear.The doctor advises chemotherapy again.Due to illness people's body constitution weakness is conscious of daring not accept.Desire adopts treatment by Chinese herbs, takes the Chinese medicine composition of this kind orally taken for curing nasopharyngeal carcinoma then, and sb.'s illness took a favorable turn after two courses of treatment, and lump reduces, and continues to take to turn for the better by and large stable disease three courses of treatment.
Example two: Liu, the man, 55 years old, the patient unfortunately was diagnosed as nasopharyngeal carcinoma in August, 2004, has and then done chemotherapeutic treatment, headache, shank arthritis appear after the chemotherapy, stomach discomfort, side effect such as blood pressure height, health is in the flue quickly many, therefore abandoned western medical treatment, come my institute to accept Chinese traditional treatment on the 7th in December in 2005.The Chinese medicine composition of taking this kind orally taken for curing nasopharyngeal carcinoma is after two courses of treatment, and the state of an illness takes a turn for the better to some extent, and headache reduces, and arthralgia disappears.After the 3rd course of treatment, be clearly better, blood pressure is also normal, present stable disease, and health is good day by day, and Mr. Liu still adheres to institute's consultation of doctors regularly, in the hope of better rehabilitation.
Example three: Wang, the woman, 53 years old, the patient is diagnosed as nasopharyngeal carcinoma in May, 2004 because of nose bleeding, tinnitus behind local examination in hospital, with the radiotherapy of After-market the People's Hospital, temporarily take a turn for the better after the radiotherapy, headache appears but rise in July, 2004, between exhausting property nose bleeding, left facial part and tongue left side is apathetic, the symptom of left neck lymphadenectasis.In my institute of in January, 2005, accept treatment by Chinese herbs.Full headache ends after ten days, and nose bleeding stops after 20 days, and the medication of going home was checked after one month: the poke lymph node disappears, and the nasopharynx part lump obviously dwindles.Continue to take check nasopharynx part lump complete obiteration after three months.
The specific embodiment
Example one: a kind of Chinese medicine composition of orally taken for curing nasopharyngeal carcinoma, making the raw materials of effective components medicine by following weight is: Gypsum Fibrosum 40 grams, Radix et Rhizoma Rhei (processed) 6 grams, Rhizoma Chuanxiong 5 grams, the Radix Angelicae Dahuricae 5 grams, Periostracum Cicadae 4 grams, the Radix Rehmanniae 30 grams, Radix Scrophulariae 30 grams, Cortex Moutan 10 grams, Preparatum Glycyrrhizae's 10 grams, Flos Lonicerae 10 grams, Spica Prunellae 20 grams and Radix Glycyrrhizae 6 grams.
Be decocted in water for oral dose.1 dose of every day, fry in shallow oil 2 times sub-service sooner or later for every dose.

Claims (1)

1. the Chinese medicine composition of an orally taken for curing nasopharyngeal carcinoma, it is characterized in that, making the raw materials of effective components medicine by following weight is: Gypsum Fibrosum 40 grams, Radix et Rhizoma Rhei (processed) 6 grams, Rhizoma Chuanxiong 5 grams, the Radix Angelicae Dahuricae 5 grams, Periostracum Cicadae 4 grams, the Radix Rehmanniae 30 grams, Radix Scrophulariae 30 grams, Cortex Moutan 10 grams, Preparatum Glycyrrhizae's 10 grams, Flos Lonicerae 10 grams, Spica Prunellae 20 grams and Radix Glycyrrhizae 6 grams.
CN2007100161179A 2007-06-29 2007-06-29 Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer Expired - Fee Related CN101104031B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100161179A CN101104031B (en) 2007-06-29 2007-06-29 Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100161179A CN101104031B (en) 2007-06-29 2007-06-29 Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer

Publications (2)

Publication Number Publication Date
CN101104031A CN101104031A (en) 2008-01-16
CN101104031B true CN101104031B (en) 2010-11-10

Family

ID=38998238

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100161179A Expired - Fee Related CN101104031B (en) 2007-06-29 2007-06-29 Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer

Country Status (1)

Country Link
CN (1) CN101104031B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103055214A (en) * 2013-01-05 2013-04-24 马长林 Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101530461B (en) * 2008-03-13 2012-06-06 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating nasopharyngeal cancer
CN104288406A (en) * 2014-11-04 2015-01-21 所俊强 Synergetic medicinal composition for nasopharynx cancer chemoradiotherapy
CN104784441B (en) * 2015-04-23 2018-11-13 侯立泳 A kind of pharmaceutical composition of prevention nasopharyngeal carcinoma radiotherapy infectious-related complication

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075087A (en) * 1993-01-01 1993-08-11 古模发 Nasopharyngeal carcinoma mixture (II type) and production technology thereof
CN1267532A (en) * 1999-03-19 2000-09-27 广东医学院 Biaining as one medicine for nasopharyngeal cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075087A (en) * 1993-01-01 1993-08-11 古模发 Nasopharyngeal carcinoma mixture (II type) and production technology thereof
CN1267532A (en) * 1999-03-19 2000-09-27 广东医学院 Biaining as one medicine for nasopharyngeal cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103055214A (en) * 2013-01-05 2013-04-24 马长林 Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia

Also Published As

Publication number Publication date
CN101104031A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
CN103301400B (en) A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis
CN103156984B (en) Traditional Chinese medicine composition for treating gingivitis and preparation method thereof
CN103182039B (en) Medicament for treating syphilis, and preparation method thereof
CN101104031B (en) Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer
CN103751691B (en) A kind of medicine for the treatment of eczema
CN103550709A (en) Traditional Chinese medicine for treating chronic pelvic inflammation
CN102805834B (en) Drug for curing gastritis and preparation method thereof
CN102133369B (en) Traditional Chinese medicine composition for treating acute cholecystitis
CN102225191B (en) Traditional Chinese medicine preparation for treating acute enteritis
CN104398733A (en) Traditional Chinese medicine preparation for treating liver depression and qi stagnation type thyroid cancer
CN105833084A (en) Traditional Chinese medicine for treating oral ulcers
CN105327171A (en) Traditional Chinese medicine electuary for treating mastitis and preparing method thereof
CN105106802A (en) Traditional Chinese medicine composition for treating peripheral facial paralysis
CN104998074A (en) Traditional Chinese medicine for treating gastropathy and preparation method thereof
CN104258206A (en) Traditional Chinese medicine preparation for treating acute glomerulonephritis
CN104306872A (en) Traditional Chinese medicine for treating uterine fibroid
CN103784806A (en) Traditional Chinese medicine for treating wind-heat urticaria
CN105106846B (en) Treat the formula of Chinese materia medica preparation of uterus adenomyosis
CN102698102A (en) Traditional Chinese medicament for treating chronic laryngitis
CN105853933A (en) Traditional Chinese medicine preparation for treating postoperative recurrence and metastasis of breast cancer and preparing method
CN105770651A (en) Traditional Chinese medicine for treating wind-heat type common cold
CN105232661A (en) Traditional Chinese medicine composition for treating mastitis and preparation method thereof
CN105147845A (en) Traditional Chinese medicine for treating stomach fire toothache
CN105106444B (en) A kind of composition that treating mumps and preparation method
CN105168944A (en) Traditional Chinese medicinal composition for treating breast cancer and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: FENG GUIQING

Free format text: FORMER OWNER: LI WEN

Effective date: 20100709

Owner name: LIU YING ZHANG WEIHONG

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Feng Guiqing

Inventor after: Liu Ying

Inventor after: Zhang Weihong

Inventor after: Li Wen

Inventor before: Li Wen

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250014 NO.66, JINGSHI ROAD, LIXIA DISTRICT, JINAN CITY, SHANDONG PROVINCE TO: 252000 LIAOCHENG HOSPITAL, NO.67, DONGCHANG WEST ROAD, LIAOCHENG CITY, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: LI WEN TO: FENG GUIQING LIU YING ZHANG WEIHONG LI WEN

TA01 Transfer of patent application right

Effective date of registration: 20100709

Address after: 252000 Shandong city of Liaocheng Province Dongchang Road No. 67 Liaocheng People's Hospital

Applicant after: Feng Guiqing

Co-applicant after: Liu Ying

Co-applicant after: Zhang Weihong

Address before: 250014, No. ten, No. 66, Lixia District, Ji'nan City, Shandong Province

Applicant before: Li Wen

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101110

Termination date: 20110629